Pressmeddelanden

REG MAR
PILA PHARMA'S BOARD OF DIRECTORS ANNOUNCES COMPLETION OF A FULLY SUBSCRIBED DIRECTED ISSUE OF APPROXIMATELY SEK 10 MILLION NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAN...
REG MAR
PILA PHARMA INKS AGREEMENT WITH LINDUS HEALTH ABOUT NEXT CLINICAL TRIAL WITH SAFETY AND OBESITY READOUTS PILA PHARMA AB (publ) (FN STO:PILA) today announces it has entered into agreement with a United Kingdom based clinical research organisation, Lindus Health, on supply of  clinica...
REG MAR
PILA PHARMA'S BOARD OF DIRECTORS HAS RESOLVED TO CARRY OUT A DIRECTED ISSUE OF SHARES OF APPROXIMATELY SEK 10.0 MILLION NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAN...
Clarification: PILA PHARMA SPONSORS INTERNATIONAL DIABETES & NUTRITION CONFERENCE Dispatch missing first section with scientific meeting information. PILA PHARMA today announces it's participation in and co-sponsorship of the 41st International Symposium on D...
PILA PHARMA SPONSORS INTERNATIONAL DIABETES & NUTRITION CONFERENCE PILA PHARMA today announces it's participation in and co-sponsorship of the 41st International Symposium on Diabetes and Nutrition, organized by the Diabetes and Nutrition Study...
PILA PHARMA PRESENTS TOMORROW AT "AKTIESPARARNA" PILA PHARMA AB (publ) (FN STO: PILA) announces that it will present tomorrow at the Aktiespararna's "Store Aktiedagarna" event.
Visa fler pressmeddelanden

Rapporter

Video

Finansiell kalender

Halvårsrapport 2024 Delårsrapport
Bokslutskommuniké 2024 Bokslutskommuniké

Om PILA PHARMA

Prenumerera

Få löpande information från PILA PHARMA via e-post.

Handelsinformation

Kurs ()
Förändring ()
Marknad Nasdaq First North Growth Market Kortnamn PILA ISIN-kod SE0015988274 Certified Adviser Aqurat Fondkommission